Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers

Area of Science:

• Oncology
• Endocrinology
• Surgical Oncology

Background:

• Differentiated thyroid cancers (DTCs) diagnosis and management remain controversial despite advancements.
• The 2015 American Thyroid Association (ATA) guidelines suggest less aggressive management, raising clinical concerns about recurrence and metastasis.

Purpose of the Study:

• To review the current state of the art in DTC diagnosis and management.
• To address uncertainties and opportunities for future research in key areas of DTC treatment.

Main Methods:

• Review of current literature and guidelines on differentiated thyroid cancers.
• Analysis of controversies in fine needle aspiration interpretation, surgical extent, radioactive iodine therapy, and targeted treatments.

Main Results:

• Management of indeterminate thyroid nodules, especially with genetic markers, is an area of uncertainty.
• The extent of surgery and the role of adjuvant radioactive iodine (RAI) therapy for DTCs require further clarification.
• Novel targeted treatments, including tyrosine kinase inhibitors (TKIs), represent emerging therapeutic options.

Conclusions:

• Significant controversies persist in DTC management, necessitating further research.
• Addressing uncertainties in nodule diagnosis, surgical strategies, RAI use, and targeted therapies is crucial for optimizing patient outcomes.
• Future research should focus on refining diagnostic criteria and therapeutic approaches for DTCs.